Turn­ing the ta­ble on CD47, Penn team primes macrophages to ig­nore 'don't eat me' sig­nal

The grow­ing group of biotechs pur­su­ing the CD47 “don’t eat me” path­way has large­ly fo­cused on dis­rupt­ing how the im­muno­sup­pres­sant lulls macrophages in­to sleep, there­by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA